Medplum vs Amgen

Side-by-side comparison of AI visibility scores, market position, and capabilities

Amgen leads in AI visibility (88 vs 38)
Medplum logo

Medplum

EmergingHealthcare

General

"Firebase for healthcare" open-source FHIR EHR API infrastructure; YC S22 $550K with $1.2M revenue serving thousands of health tech developers competing with Google Cloud Healthcare API for HIPAA-compliant infrastructure.

AI VisibilityBeta
Overall Score
D38
Category Rank
#461 of 596
AI Consensus
81%
Trend
stable
Per Platform
ChatGPT
39
Perplexity
32
Gemini
36

About

Medplum is a San Francisco-based open-source EHR and healthcare API infrastructure company — often described as "Firebase for healthcare" — providing FHIR-compliant API infrastructure, clinical data management, and workflow tools that healthcare developers use to build EMR-adjacent applications, care management platforms, and health tech products without building from scratch the compliance, data modeling, and interoperability layers that healthcare applications require. Founded in 2021 and backed by Y Combinator (S22) with $550,000 raised, Medplum achieved $1.2 million in revenue in 2024 serving thousands of developers globally building on the open-source platform.

Full profile
Amgen logo

Amgen

LeaderHealthcare Tech

AI Drug Discovery

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI VisibilityBeta
Overall Score
A88
Category Rank
#3 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
87
Gemini
85

About

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Full profile

AI Visibility Head-to-Head

38
Overall Score
88
#461
Category Rank
#3
81
AI Consensus
78
stable
Trend
stable
39
ChatGPT
83
32
Perplexity
87
36
Gemini
85
40
Claude
90
38
Grok
92

Key Details

Category
General
AI Drug Discovery
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Amgen
AI Drug Discovery

Integrations

Amgen is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.